Specific antitumor activity and mechanism of protonic bis-phenanthroline
10.16438/j.0513-4870.2021-1553
- VernacularTitle:质子型双菲啰啉的特异性抗肿瘤活性及其机制研究
- Author:
Zi-zhen ZHAO
;
Chen FU
;
Zhi-hong CUI
;
Xiao-rong LI
;
Ying-ying ZHANG
;
Yu-ping ZHANG
;
Xiao-xi YANG
;
Ai-ling FU
- Publication Type:Research Article
- Keywords:
hepatocellular carcinoma;
protonic bis-phenanthroline;
pleomorphic adenoma gene like-2;
apoptosis;
hydrogen bond
- From:
Acta Pharmaceutica Sinica
2022;57(5):1344-1351
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) is a common malignant tumor worldwise. The incidence rate of HCC is high and is easy to metastasis and recurrence, which seriously affects human health. Traditional chemical drugs have some challenges such as toxicity, side effects, and multidrug resistance, thus it is urgent to find new drugs and effective targets. Here we synthesized a novel chemical, protonic bis-phenanthroline (H-BP), and the antitumor effect was investigated in the study. The results showed that H-BP could selectively inhibit the proliferation of tumor cells and cause HCC apoptosis. And also, in HCC tumor-bearing mice, H-BP could effectively prevent the growth of tumor mass, even completely eliminate the tumor at medium dose (5 mg·kg-1) and high dose (10 mg·kg-1), and meanwhile H-BP has no significant effect on the body weight of mice. The experimental protocol was approved by the Animal Ethics Committee of Southwest University, and the experimental operation was strictly carried out in accordance with the ethical principles of animal use and care. Mechanism studies showed that H-BP induced HCC apoptosis was related to down-regulation the expression of pleomorphic adenoma gene like-2 (PLAGL2), a oncogene transcription factor, resulting in the down-regulation of PLAGL2 downstream proteins hypoxia inducible factor and β-catenin. This study not only introduces the dimerization method to form novel compounds that will provide a new approach for drug design, but also suggests that PLAGL2 may be an effective target in tumor therapy.
